Heterozygous NOTCH1 Variants Cause CNS Immune Activation and Microangiopathy

Ann Neurol. 2022 Nov;92(5):895-901. doi: 10.1002/ana.26477. Epub 2022 Aug 20.

Abstract

NOTCH1 belongs to the NOTCH family of proteins that regulate cell fate and inflammatory responses. Somatic and germline NOTCH1 variants have been implicated in cancer, Adams-Oliver syndrome, and cardiovascular defects. We describe 7 unrelated patients grouped by the presence of leukoencephalopathy with calcifications and heterozygous de novo gain-of-function variants in NOTCH1. Immunologic profiling showed upregulated CSF IP-10, a cytokine secreted downstream of NOTCH1 signaling. Autopsy revealed extensive leukoencephalopathy and microangiopathy with vascular calcifications. This evidence implicates that heterozygous gain-of-function variants in NOTCH1 lead to a chronic central nervous system (CNS) inflammatory response resulting in a calcifying microangiopathy with leukoencephalopathy. ANN NEUROL 2022;92:895-901.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Central Nervous System / metabolism
  • Chemokine CXCL10
  • Ectodermal Dysplasia*
  • Humans
  • Leukoencephalopathies*
  • Receptor, Notch1 / genetics
  • Receptor, Notch1 / metabolism

Substances

  • Receptor, Notch1
  • Chemokine CXCL10
  • NOTCH1 protein, human